You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Recruiting
  • Multiple Myeloma
  • +2 more
  • BCMA CAR-T cells
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
2021-03-01
Mar 1, 2021
C
Recruiting
  • Leukemia
  • +2 more
  • CD123 CAR-T cells
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
2021-03-01
Mar 1, 2021
I
Recruiting
  • CAR-T Therapy Complications
    • Bologna, Italy
      IRCC, University Hospital of Bologna
    2021-05-14
    May 14, 2021
    M
    Recruiting
    • Lymphoma Receiving CAR-T Therapy
    • neurocognitive evaluations
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    2021-10-01
    Oct 1, 2021
    Z
    Not yet recruiting
    • Non-hodgkin Lymphoma,B Cell
    • CD19 CAR-T cells
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital,College of Medicine, Zhejiang Univ
    2020-12-03
    Dec 3, 2020
    C
    Recruiting
    • Leukemia
    • +3 more
    • CD19 CAR-T cells
    • Chongqing, Chongqing, China
      Chongqing University Cancer Hospital
    2021-03-01
    Mar 1, 2021
    T
    Recruiting
    • Allogenic Hematopoietic Cell Transplant
    • +2 more
      • Tel-Aviv, Israel
        Tel-Aviv Sourasky Medical Center
      2021-01-27
      Jan 27, 2021
      Z
      Recruiting
      • B-Cell Acute Lymphoblastic Leukemia, Adult
      • CAR-T cells targeting CD19 and CD22
      • Hangzhou, Zhejiang, China
        The First Affiliated Hospital, College of Medicine, Zhejiang Uni
      2021-03-05
      Mar 5, 2021
      Z
      Recruiting
      • B-Cell Acute Lymphoblastic Leukemia, Adult
      • CAR-T cells targeting CD19 and CD22
      • Hangzhou, Zhejiang, China
        The First Affiliated Hospital, College of Medicine, Zhejiang Uni
      2021-02-04
      Feb 4, 2021
      C
      Recruiting
      • Solid Tumor
      • +6 more
      • CEA CAR-T cells
      • Chongqing, Chongqing, China
        Chongqing University Cancer Hospital
      2020-08-30
      Aug 30, 2020
      C
      Recruiting
      • Leukemia, B-cell
      • Lymphoma, B-Cell
      • CD19 and CD22 targeted CAR-T cells
      • Chongqing, Chongqing, China
        Chongqing University Cancer Hospital
      2021-03-01
      Mar 1, 2021
      C
      Recruiting
      • Leukemia, B-cell
      • Lymphoma, B-Cell
      • CD19 and CD22 targeted CAR-T cells
      • Kunming, Yunnan, China
        920th Hospital of Joint Logistics Support Force
      2020-11-29
      Nov 29, 2020
      C
      Recruiting
      • AML M4
      • AML M5
      • anti-ILT3 CAR-T
      • Hangzhou, Zhejiang, China
        Zhejiang Provincal People's Hospital
      2021-03-19
      Mar 19, 2021
      L
      Active, not recruiting
      • Refractory B-Cell Non-Hodgkin Lymphoma
      • Refractory Leukemia
      • Modified anti-CD19 CAR T cells
      • Chengdu, Sichuan, China
        Sichuan University
      2021-03-17
      Mar 17, 2021
      Z
      Recruiting
      • Acute Lymphoblastic Leukemia
      • Non-Hodgkin Lymphoma of Soft Tissue
      • Murine CD19 CAR-T cells
      • Hangzhou, Zhejiang, China
        The First Affiliated Hospital,College of Medicine, Zhejiang Univ
      2020-10-22
      Oct 22, 2020
      Z
      Not yet recruiting
      • Relapsed and/or Refractory Acute Lymphoblastic Leukemia
      • Relapsed and/or Refractory B-cell Non-Hodgkin's Lymphoma
      • CD79b CAR-T Cells
      • Hangzhou, Zhejiang, China
        The First Affiliated Hospital, College of Medicine, Zhejiang Uni
      2020-10-23
      Oct 23, 2020
      X
      Not yet recruiting
      • Leukemia, Myeloid, Acute
      • Chongqing, Chongqing, China
        Department of Hematology, Xinqiao Hospital
      2021-08-20
      Aug 20, 2021
      T
      Recruiting
      • Nectin4-positive Advanced Malignant Solid Tumor
      • CAR-T therapy for nectin4-positive malignant solid tumor
      • Lishui, Zhejiang, China
      • +1 more
      2020-11-16
      Nov 16, 2020
      T
      Active, not recruiting
      • Acute Lymphoblastic Leukemia, Adult B-Cell
      • CAR-T infusion
      • Suzhou, Jiangsu, China
        The First Affliated Hospital of Soochow University
      2021-08-16
      Aug 16, 2021
      I
      Recruiting
      • Diffuse Large B Cell Lymphoma
      • Tianjin, China
        Institute of Hematology & Blood Diseases Hospital
      2020-03-18
      Mar 18, 2020
      T
      Recruiting
      • RRMM
      • CAR-T therapy in Relapsed/Refractory multiple myeloma
      • Lishui, Zhejiang, China
      • +2 more
      2020-11-16
      Nov 16, 2020
      S
      Recruiting
      • Relapsed or Refractory Multiple Myeloma
      • anti-BCMA CAR-T
      • +2 more
      • Hangzhou, Zhejiang, China
        2nd Affiliated Hospital, School of Medicine, Zhejiang University
      2021-04-04
      Apr 4, 2021
      Z
      Not yet recruiting
      • Relapse Multiple Myeloma
      • CS1 Targeted CAR T-cells
      • Hangzhou, Zhejiang, China
        The First Affiliated Hospital,College of Medicine, Zhejiang Univ
      2020-12-09
      Dec 9, 2020
      H
      Recruiting
      • Diffuse Large-Cell Lymphoma
      • +3 more
      • Pneumococcal conjugate vaccine (PCV13)
      • CD19 targeted CAR T Cell Therapy
      • Tampa, Florida
        Moffitt Cancer Center
      2021-07-12
      Jul 12, 2021
      S
      Recruiting
      • MRD-positive
      • Acute Lymphoblastic Leukemia
      • anti-CD19/CD22 CAR-T cells
      • +2 more
      • Shanghai, Shanghai, China
        Shanghai General Hospital
      2021-09-23
      Sep 23, 2021